We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

APR 19 2021

Will Section viii Labeling Carve-Outs Survive GSK v. Teva? - Legal ERA

Brian Gold and Grant Shackelford, associates in the firm’s Intellectual Property section, co-authored an article in Legal ERA, "Will Section viii Labeling Carve-Outs Survive GSK v. Teva?" The full article can also be viewed here.

This article "Will section viii labelling carve-outs survive GSK v. Teva?" was first published on www.legaleraonline.com on April 12, 2021 & was also published in & Legal Era Magazine April 2021 Edition.